Error as occured...

Side Event #6456

Status: SCHEDULED

Date Monday
2024.10.21 @ 18:00
Add to Calendar
Room Sierra Nevada - Working Group II
CEVP Ground floor
Capacity: 857 people
Conference SBI-05 / COP-16 / CP-MOP-11 / NP-MOP-05
Meetings(s)
COP-16
Sixteenth meeting of the Conference of the Parties to the Convention on Biological Diversity
Title Digital Sequence Information and Global Biodiversity Finance: Revenue Mobilization Options
Hosts
LSE | GRI | OBC | One World Analytics |
Topics
Digital Sequence Information on Genetic Resources
Access to Genetic Resources and Benefit-sharing
 

 

In 2022 COP15 of the Convention on Biological Diversity (CBD) adopted the Global Biodiversity Framework and a Resource Mobilisation Strategy directed to raising an additional $200 billion a year for its implementation. At the same time, the COP also decided to create a multilateral mechanism and global fund for the sharing of the benefits arising from digital sequence information (DSI) (genetic sequence data). Genetic sequence data is a key global resource powering developments in biotechnology, agriculture, health and emerging developments in artificial intelligence.

 

At COP16 Parties to the Convention are likely to address several clusters of questions around the new DSI fund such as:

  1. Size: What criteria could be used to assist decision makers with determining the appropriate volume for the new fund on digital sequence information?
  2. Contributions: What measures (such as profit, turnover, the value of exports) are available to assist decision-makers with deciding on appropriate models for contributions to the fund by different actors from different economies (e.g. governments, industry, research organisations, the general public)?
  3. Organisation: Drawing on lessons learned with other funding mechanisms, how could contributions to, and disbursements from, the global fund best be organised and accounted for (e.g. should the global fund have national and regional elements or be centralised in one entity)?
  4. Relationships: the relationship between bilateral benefit-sharing for genetic resources and digital sequence information and other international instruments and processes, including, inter alia,  the new Oceans Treaty (BBNJ), the Plant Treaty and the WHO Pandemic Preparedness Agreement.

 

Bearing in mind these clusters of related questions, this event will bring together a number of experts to first, give an overview, and secondly to consider the feasibility of a number of proposals on the table for revenue generation. These options include a percentage of sales of individual commercial products that have been developed using digital sequence information; X % of turnover, profit or exports from relevant sectors substantially reliant on digital sequence information; charges against the use of the biodiversity and life science infrastructure using cloud pricing models (Big Data and Artificial Intelligence); a contribution of 1 % of retail sales of biodiversity-based products sold in developed countries. Other methods that have not been considered in the CBD context includes relying on technological means of mapping aggregate usage of DSI using a range of factors comprising ‘utilization’ indicators including publications, patents and development of products (such as in the BBNJ agreement).

The event will attempt to bring different kinds of data, mapping and measurement to an understanding of the revenue mobilization.

Error as occured...
File Title & Description Tags

Digital Sequence Information in the UN High Seas Treaty: Insights from the Global Biodiversity Framework-related Decisions


In December 2022, the 15th Conference of the Parties (COP) to the Convention on Biological Diversity (CBD) adopted the Global Biodiversity Framework. The Decisions taken in support of the Framework represent a significant phase shift in the approach to governance of digital sequence information (DSI) on genetic resources. The authors observe that these, particularly CBD Decision 15/9, have significant implications for fraught negotiations on a proposed new UN Treaty on Biodiversity Beyond National Jurisdiction. They analyse shifting baselines on digital sequence information, data governance, transparency in use and circulation of genetic resources and monetary benefit sharing to suggest that the Global Biodiversity Framework-related Decisions provide an important and hard-won equitable road map whose key elements can be adapted to address digital sequence information (DSI) in the high seas context.

papers.cfm

Digital Sequence Information, UN High Seas Treaty  

The Pandemic Access and Benefit Sharing System: Four Elements of a Trusted System


Member states of the World Health Organisation are negotiating a new international agreement on pandemic preparedness and updates to the International Health Regulations. One of the most contentious issues in negotiations on the Pandemic Accord is access to pandemic materials and information and benefit-sharing. On the one hand developing countries are seeking to overcome the severe problem of inequity in access to vaccines and other products revealed during the last pandemic. On the other, developed countries are seeking access to samples and sequences from pathogens with no binding obligations to share benefits. The key focus of contestation is the design of the Pandemic Access and Benefit-Sharing System, or PABS. In this paper we seek to find constructive middle ground by arguing that it is important to focus on elements that build trust that are based on the core interests of both developed and developing countries. To that end we outline the Pandemic Access and Benefit-Sharing Umbrella consisting of four elements: a WHO Coordinated Laboratory and Database Network, a PABS Licence, a PABS Register and an Intellectual Property Framework. We also set out in detail the means of funding of the PABS Umbrella through tiered contributions from State Parties. By adopting the familiar architecture of a PABS License to build certainty of obligations and responsibilities our model does away with the need to contract individually with manufacturers of products, and provides significant incentive in the form of access to pathogenic materials and information to all who register without discrimination of type of entity; while developing a PABS Register modelled on the EU Horizon programme as an asset that can be mobilized for pandemic preparedness. The PABS License includes the potential for reach-through terms on intellectual property and a triple lock mechanism that provides certainty on when constraints on the exploitation of such rights may be imposed. While elements of the model are prescriptive in outline, the scope of it is capable of holding a range of diverse interests aligned with both developed and developing countries. By building elements of trust, embedding incentives, and constructing assets that work for everybody, the PABS umbrella and IP-framework provides the basis to achieve protection for the populations of all state parties during pandemics.

papers.cfm

Pandemic Treaty, PABS, Access and Benefit Sharing, License, Pathogens of pandemic potential, monetary contributions, genetic resources  

Error as occured...
File Title & Description Tags


 

Error as occured...
File Title & Description Tags


 

Documents